Search Results 811-820 of 16375 for pharmacogenetics
Researchers are leading the nation in developing powerful and precise radiopharmaceutical theranostics intended to treat people with deadly cancers.
Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.
The Knowledge Synthesis Program in the Mayo Clinic Kern Center for the Science of Health Care Delivery identifies and examines knowledge to apply the best ...
Type: Fellowship; Duration: 1 year; School: Graduate Medical Education; Specialty: Laboratory Medicine & Pathology ...
We are doing this study to compare how acute maximal and acute endurance exercise affect immune cell populations in the blood for different populations of ...
Mayo Clinic researchers report that healthy adults with slower metabolic rates are not at higher risk for weight gain. The finding, which appears in the[...].
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
This phase II trial studies how well daunorubicin hydrochloride, cytarabine, and nilotinib work in treating patients newly diagnosed with acute myeloid leukemia ...
About this study. Specific mutations relating to hyperoxaluria will be determined via DNA analysis by the Mayo RKSC research staff.
John B. Kisiel, M.D., a gastroenterologist at Mayo Clinic's campus in Rochester, Minnesota, discusses a study that identified the source of cancer in ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.